PRIMARY STUDY

Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway

Key Findings:  Data indicates that CBD may exert preventive and protective actions (via activation CB2 and TRPV1 receptor sites) in patient with PD.

Type of Study:  Laboratory Study

Study Result:  Positive


Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype III

Form of Administration:  Not Applicable

Receptors Studied:  CB2, TRPV1


Study Location(s):  Italy

Year of Pub:  2020


Link to study